These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7165357)

  • 1. Kinetics of [14C-5] 8-methoxypsoralen distribution in rabbits.
    Malinin GI; Glew WB; Roberts WP; Townsend L; Nigra TP
    Arch Dermatol Res; 1982; 273(3-4):319-26. PubMed ID: 7165357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of [14C-5] 8-methoxypsoralen uptake by UVA irradiated and non-irradiated rabbit eye tissues.
    Malinin GI; Glew WB; Roberts WP; Nigra TP
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):223-34. PubMed ID: 7244361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin concentration of 8-methoxypsoralen, 5-methoxypsoralen and 4,5,8-trimethylpsoralen in guinea pigs.
    Park YK; Hann SK; Im S; Kim S
    J Dermatol Sci; 1993 Feb; 5(1):19-24. PubMed ID: 8485109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the anti-psoriatic agent 5-methoxypsoralen in humans: comparison with rat and dog.
    John BA; Chasseaud LF; Wood SG; Forlot P
    Xenobiotica; 1992 Nov; 22(11):1339-51. PubMed ID: 1492426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration kinetics of 8-methoxypsoralen after 8-methoxypsoralen bath procedure with and without UVA irradiation.
    Neumann NJ; Grosse OJ; Ruzicka T; Lehmann P
    Skin Pharmacol Appl Skin Physiol; 2001; 14(4):210-6. PubMed ID: 11464103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, distribution, and excretion of 8-methoxypsoralen in HRA/Skh mice.
    Muni IA; Schneider FH; Olsson TA; King M
    Natl Cancer Inst Monogr; 1984 Dec; 66():85-90. PubMed ID: 6531044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Methoxypsoralen levels in blood of vitiligo patients and in skin, ophthalmic fluids, and ocular tissues of the guinea pig.
    Chakrabarti SG; Halder RM; Johnson BA; Minus HR; Pradhan TK; Kenney JA
    J Invest Dermatol; 1986 Aug; 87(2):276-9. PubMed ID: 3734475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of 3H-8-MOP and its metabolites in rat organs after a single oral administration.
    Wulf HC; Andreasen MP
    J Invest Dermatol; 1981 Apr; 76(4):252-8. PubMed ID: 7205026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites.
    Mays DC; Rogers SL; Guiler RC; Sharp DE; Hecht SG; Staubus AE; Gerber N
    J Pharmacol Exp Ther; 1986 Feb; 236(2):364-73. PubMed ID: 3944766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary intake and risk assessment of phototoxic furocoumarins in humans.
    Schlatter J; Zimmerli B; Dick R; Panizzon R; Schlatter C
    Food Chem Toxicol; 1991 Aug; 29(8):523-30. PubMed ID: 1894218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Methoxypsoralen (8-MOP) in human skin: penetration kinetics.
    Gazith J; Schalla W; Bauer E; Schaefer H
    J Invest Dermatol; 1978 Aug; 71(2):126-30. PubMed ID: 681780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and accumulation of radioactivity in mice following administration of 14C-8-MOP and 3H-8-MOP: an autoradiographic study.
    Wulf HC
    Photodermatol; 1984 Dec; 1(6):293-7. PubMed ID: 6533620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of tritium-labelled 8-methoxypsoralen in the rat, studied by whole body autoradiography.
    Wulf HC; Hart J
    Acta Derm Venereol; 1979; 59(2):97-103. PubMed ID: 84506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraindividual variations of 8-methoxypsoralen plasma levels.
    Schäfer-Korting M; Korting HC
    Arch Dermatol Res; 1982; 272(1-2):1-7. PubMed ID: 7165313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photobiological activity of suction blister fluid from patients treated with 8-methoxypsoralen.
    Dubertret L; Averbeck D; Prognon P; Blais J; Vigny P
    Br J Dermatol; 1983 Oct; 109(4):421-7. PubMed ID: 6354243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination by bioassay of photoactive 8-methoxypsoralen in serum.
    Glew WB; Roberts WP; Malinin GI; Nigra TP
    J Invest Dermatol; 1980 Sep; 75(3):230-4. PubMed ID: 7410889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoinactivation of skin fibroblasts by fractionated treatment with 8-methoxypsoralen and UVA.
    Pohl J; Christophers E
    J Invest Dermatol; 1979 Aug; 73(2):176-9. PubMed ID: 458191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation and removal of 8-MOP-DNA photoadducts in keratinocytes: effects of calcium concentration and retinoids.
    Tokura Y; Edelson RL; Gasparro FP
    J Invest Dermatol; 1991 Jun; 96(6):942-9. PubMed ID: 2045683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-Methoxypsoralen and long-wave ultraviolet A inhibit the release of proinflammatory mediators and cytokines from human Fc epsilon RI+ cells: an in vitro study.
    de Paulis A; Monfrecola G; Casula L; Prizio E; Di Gioia L; Carfora M; Russo I; de Crescenzo G; Marone G
    J Photochem Photobiol B; 2003 Mar; 69(3):169-77. PubMed ID: 12695031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of apoptosis induction in human cell lines by UVA and 8-MOP.
    Vowels BR; Yoo EK; Gasparro FP
    Photochem Photobiol; 1996 May; 63(5):572-6. PubMed ID: 8628747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.